- Home
- LEGN vs SNEX Comparison
LEGN vs SNEX Comparison
Compare LEGN & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- SNEX
- Stock Information
- Founded
- LEGN 2014
- SNEX 1924
- Country
- LEGN United States
- SNEX United States
- Employees
- LEGN N/A
- SNEX N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- SNEX Investment Bankers/Brokers/Service
- Sector
- LEGN Health Care
- SNEX Finance
- Exchange
- LEGN Nasdaq
- SNEX Nasdaq
- Market Cap
- LEGN 6.3B
- SNEX 5.3B
- IPO Year
- LEGN 2020
- SNEX 1994
- Fundamental
- Price
- LEGN $31.46
- SNEX $98.15
- Analyst Decision
- LEGN Strong Buy
- SNEX Buy
- Analyst Count
- LEGN 12
- SNEX 1
- Target Price
- LEGN $73.36
- SNEX N/A
- AVG Volume (30 Days)
- LEGN 1.2M
- SNEX 517.9K
- Earning Date
- LEGN 11-11-2025
- SNEX 11-18-2025
- Dividend Yield
- LEGN N/A
- SNEX N/A
- EPS Growth
- LEGN N/A
- SNEX 21.85
- EPS
- LEGN N/A
- SNEX 5.86
- Revenue
- LEGN $796,838,000.00
- SNEX $129,411,800,000.00
- Revenue This Year
- LEGN $69.31
- SNEX N/A
- Revenue Next Year
- LEGN $52.73
- SNEX $22.66
- P/E Ratio
- LEGN N/A
- SNEX $16.75
- Revenue Growth
- LEGN 74.75
- SNEX 53.56
- 52 Week Low
- LEGN $27.34
- SNEX $54.60
- 52 Week High
- LEGN $51.77
- SNEX $106.98
- Technical
- Relative Strength Index (RSI)
- LEGN 31.45
- SNEX 50.52
- Support Level
- LEGN $32.02
- SNEX $97.40
- Resistance Level
- LEGN $32.62
- SNEX $105.33
- Average True Range (ATR)
- LEGN 1.02
- SNEX 3.16
- MACD
- LEGN -0.09
- SNEX 0.09
- Stochastic Oscillator
- LEGN 6.87
- SNEX 54.68
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.